METHODS AND COMPOSITIONS FOR RESTORING STMN2 LEVELS

Application of GLUN2A and NMDA Receptor Containing GLUN2A as Targets in Screening Drugs for Treating Depression

METHODS AND RELATED ASPECTS FOR DETERMINING COGNITIVE STATUS ASSOCIATED WITH PARKINSON'S DISEASE

METHOD OF EVALUATING INTERCELLULAR INTERACTIONS IN NEUROINFLAMMATION

PRODUCTION METHOD OF THREE-DIMENSIONAL CELL CULTURE, CULTURE METHOD OF THREE-DIMENSIONAL CELL CULTURE, THREE-DIMENSIONAL CELL CULTURE, AND EVALUATION METHOD OF TEST SUBSTANCE

MICROGLIA DERIVED FROM PLURIPOTENT STEM CELLS AND METHODS OF MAKING AND USING THE SAME

Bcl2 Family in Dysfunctional Neurons Is Critical to the Evolution, Diagnosis and Treatment of Neurodegenerative Diseases Including but Not Limited to Corticobasal Degeneration, Chronic Traumatic Encephalopathy, Amyotrophic Lateral Sclerosis (Als), Alzheimer's Disease, Parkinson's Disease, Down's Syndrome Dementia, and Lewy Body Dementia

TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS

PRODUCTION METHOD OF NERVE CELLS DAMAGED BY OXIDATIVE STRESS AND APPLICATIONS THEREOF

DERIVATION OF HUMAN MICROGLIA FROM PLURIPOTENT STEM CELLS

KIT FOR DIAGNOSING ALZHEIMER'S DISEASE AND PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE

REGULATION OF IMMUNE RESPONSES THROUGH SELECTIVE NEURAL ACTIVATION

OPTOGENETIC ALPHA-SYNUCLEIN AGGREGATION SYSTEM-BASED COMPOUND SCREENING PLATFORM IN PD-hiPSC-mDA NEURONS

GENOMIC ALTERATIONS ASSOCIATED WITH SCHIZOPHRENIA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

PHARMACEUTICAL COMPOSITION FOR TREATING DISEASES RELATED TO TAUOPATHY

OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION

METHOD FOR IDENTIFYING EFFECTIVE TREATMENTS AGAINST NEURODEGENERATIVE DISORDERS

ANTI-FAM19A5 ANTIBODIES AND USES THEREOF

FKBP52-DERIVED THERAPEUTIC PEPTIDES THAT INHIBIT PATHOLOGICAL TAU AGGREGATION FOR THERAPEUTIC PURPOSES

HUMAN PLURIPOTENT STEM CELL DERIVED NEURODEGENERATIVE DISEASE MODELS ON A MICROFLUIDIC CHIP

MICROGLIAL CELLS AS THERAPEUTIC TARGETS IN NEURODEVELOPMENTAL DISORDERS

METHOD AND COMPOSITION FOR GENERATING BASAL FOREBRAIN CHOLINERGIC NEURONS (BFCNS)

METHOD FOR EVALUATING ACTIVITY OF INHIBITING OR PROMOTING AGGREGATION OF AGGREGATING PROTEINS

GENERATION OF NOREPINEPHRINE NEURONS FROM HUMAN STEM CELLS

METHOD OF NOCICEPTOR DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS AND USES THEREOF

LYOPHILIZED MESENCHYMAL STEM CELL DERIVED SECRETOME AND USES THEREOF

SYSTEMS

SCREENING METHOD AND THERAPEUTIC AGENT FOR MENTAL DISORDER

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

MODULATION OF AVERSIVE AND SALT TASTES

DEVICES FOR USE AS BLOOD BRAIN BARRIER MODELS

IN VITRO OR EX VIVO METHOD FOR DETERMINING THE EFFECT OF A BIOLOGICAL SAMPLE ON A BIOLOGICAL MODEL USING LARGE-SCALE NEURAL ACTIVITY

EPIGENOME BIOMARKERS FOR IDENTIFYING ALZHEIMER'S DISEASE

OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION

METHODS AND SYSTEMS FOR MODULATING AND MODELING AGING AND NEURODEGENERATION DISEASES

GENERATION OF NEURAL ORGANIZER ORGANOIDS AND MIDLINE ASSEMBLOIDS FROM HUMAN PLURIPOTENT STEM CELLS

METHOD FOR EVALUATING BIOLOGICAL ACTIVITY OF BIOMATERIALS

COMPOSITIONS AND METHODS FOR MODULATING NEURONAL EXCITABILITY AND MOTOR BEHAVIOR

CELL-BASED METHOD FOR DETERMINING AN ACTIVITY OF BOTULINUM TOXIN

DEORPHANIZING ODORS USING SINGLE CELL SEQUENCING

HUMAN CORTICAL ORGANOIDS WITH ENGINEERED MICROGLIA-LIKE CELLS

Marker for Neural Stem Cells

METHOD FOR SCREENING AN ACTIVE COMPOUND IN VITRO

METHOD AND SYSTEMS FOR SCALABLE CULTURE OF ENTERIC GLIA CELLS

MUTANT TDP-43 PROTEIN

UFMYLATION INHIBITION TO TARGET TAUOPATHY IN HUMAN NEURONS

Methods of Modifying Neuronal Function by Changing Intracellular Magnesium Levels

PLATFORMS FOR DRUG TESTS AGAINST SYNUCLEINOPATHY USING HUMAN BRAIN ORGANOIDS

COMPOSITIONS AND SYSTEMS COMPRISING THREE-DIMENSIONAL NERVE CELL CULTURES AND METHODS OF USING THE SAME

In Vitro Cell Co-Cultures of Neuronal Cells, Astrocytes, and Oligodendrocytes

COMBINATORIAL USE OF MARKERS TO ISOLATE SYNAPTIC GLIA TO GENERATE SYNAPSES IN A DISH FOR HIGH-THROUGHPUT AND HIGH-CONTENT DRUG DISCOVERY AND TESTING

THREE-DIMENSIONAL DIRECT NEURONAL REPROGRAMMING TO MODEL ALZHEIMER'S DISEASE IN HUMAN NEURONS

CHAPERONES AS AN AUTOPHAGY RECEPTORS FOR CLEARANCES OF PROTEIN AGGREGATES AND/OR AGGREGATION-PRONE PROTEINS

OPTICAL CLEARING AND AUTO-FLUORESCENCE QUENCHING SOLUTIONS AND METHOD OF USE FOR ENHANCED MICROSCOPY IMAGING OF BIOLOGICAL TISSUES

HUMAN CEREBELLAR ORGANOIDS WITH BONA FIDE PURKINJE CELLS AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATMENT OF RETINAL DEGENERATION

INHIBITORS OF AMYLOID BETA OLIGOMERIZATION AND THERAPEUTIC USES THEREOF

COMPOSITIONS AND METHODS FOR THE GENERATION OF NEURONS AND USES THEREOF

PLATFORM FOR TARGET DISCOVERY AND METHODS OF USE THEREOF

METHOD FOR DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDER ON BASIS OF ACTIVITY REGULATION MECHANISM OF DORMANT NEURAL STEM CELL

GLIOMA THERAPY

ASSAY FOR EXTRINSIC INHIBITION

Means and methods for the determination of the biological activity of neurotoxin polypeptides in cells

FUNCTIONAL CORTICAL ORGANOIDS, METHODS OF MAKING, AND USES THEREOF

COMPOSITION FOR PREVENTING OR TREATING OF ISCHEMIC CEREBROVASCULAR DISEASE COMPRISING AN ARGINASE-1 INHIBITOR

NEURITE OUTGROWTH PROMOTION KIT AND USE THEREFOR

SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY

DOPAMINERGIC PRECURSOR CELLS AND METHODS OF USE

NOVEL NEURONAL CELL LINE FOR MEASURING TITER OF NEUROTOXIN

METHODS AND COMPOSITIONS FOR IPSC-DERIVED MICROGLIA

NOVEL USE

TUNABLE NEURONAL NETWORK AND AN ARTIFICIAL EYE

COMPOSITIONS AND METHODS FOR TRACING CELL NETWORKS

ASSEMBLED THREE-DIMENSIONAL CULTURES OF HUMAN NEURONS AND GLIA AND THEIR USE

COMPOUNDS FOR USE IN PROGRESSIVE MULTIPLE SCLEROSIS

FUNCTIONAL BRAIN REGION-SPECIFIC NEURAL SPHEROIDS AND METHODS OF USE

DRUG FOR RETINAL DEGENERATIVE DISEASE ASSOCIATED WITH PHOTORECEPTOR DEGENERATION

THERAPIES FOR THE TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH ABNORMAL EXPRESSION OF CDKL5 GENE

NEURAL LATTICE DEVICE FOR CHARACTERIZATION OF NEURON BEHAVIOR

OLIGONUCLEOTIDES FOR INDUCING PATERNAL UBE3A EXPRESSION

RELATED FORMULATIONS AND METHODS RELATED TO EYE IRRITATION

CELL-BASED METHOD FOR DETERMINING AN ACTIVITY OF BOTULINUM TOXIN

REGULATION OF IMMUNE RESPONSES THROUGH SELECTIVE NEURAL ACTIVATION

TREATING OPTIC NEURITIS WITH INDUCED PLURIPOTENT STEM CELL-DERIVED OLIGODENDROCYTE PRECURSOR CELLS

METHODS FOR GENERATING INNER EAR HAIR CELLS

COMPOSITIONS AND METHODS FOR MODELING HUMAN MICROGLIA

TAU BIOSENSOR CELL LINES

Eyedrops for Inhibiting Myopia Progression in Children and Screening Method for Inhibitor of Myopia Progression in Children

METHOD FOR IDENTIFYING AND/OR FOR OBTAINING AN ACTIVE SUBSTANCE FOR THE TREATMENT AND THERAPY OF FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS, AND USE OF AN ACTIVE SUBSTANCE FOR THE TREATMENT OF THIS DISEASE

IPSC-DERIVED ASTROCYTES AND METHODS OF USE THEREOF

DIAGNOSTIC ASSAYS EMPLOYING NEURON-DERIVED EXOSOMES

METHOD OF ANALYZING NEURONS, DEVICE FOR ANALYZING NEURONS, AND COMPUTER PROGRAM

METHODS FOR INHIBITING CHMP7 EXPRESSION IN NEURONAL CELLS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

METHOD FOR THE GENERATION OF NEUROSPHERES

Novel Compounds

FORMULATIONS AND METHODS RELATED TO EYE IRRITATION AND RELATED

CLEC9A antibodies

COMPOSITION FOR PREVENTING OR TREATING NEUROMUSCULAR DISEASE, COMPRISING PRMT1 PROTEIN OR GENE ENCODING SAME

CORTICAL INTERNEURONS AND OTHER NEURONAL CELLS PRODUCED BY THE DIRECTED DIFFERENTIATION OF PLURIPOTENT AND MULTIPOTENT CELLS

COMPLEX MICROFLUIDIC MODELS FOR ALS INCLUDING NF BIOMARKERS FOR ALS RESEARCH AND DRUG DEVELOPMENT

NEURODEGENERATIVE TARGET DISCOVERY PLATFORM

CELLS USEFUL FOR IMMUNO-BASED BOTULINUM TOXIN SEROTYPE A ACTIVITY ASSAYS

Neuronal diencephalon stem cells, preparation and uses for treatment and prevention of hormonal disorders and other diseases

Compositions and Methods for Degradation of Misfolded Proteins

METHOD FOR INDUCING NEURONAL SYNAPSE FORMATION AND MICROBEADS USED IN SAID METHOD

GENOMIC ALTERATIONS ASSOCIATED WITH SCHIZOPHRENIA AND METHODS OF USE THEREOF FOR THE DIAGNOSIS AND TREATMENT OF THE SAME

TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS

AGENTS DIRECTED AGAINST A CIS RGMA/NEOGENIN INTERACTION OR LIPID RAFTS AND USE OF THE SAME IN METHODS OF TREATMENT

Oligonucleotides for inducing paternal UBE3A expression

ANTI-FAM19A5 ANTIBODIES AND USES THEREOF

Methods of reducing severity of glaucoma by intravitreal administration of insulin-like growth factor binding protein-like 1 (IGFBPL1)

Methods of Modifying Neuronal Function by Changing Intracellular Magnesium Levels

SYSTEM

COMPOSITION COMPRISING OSTEOPONTIN INHIBITOR AS ACTIVE INGREDIENT FOR PREVENTION, ALLEVIATION, OR TREATMENT OF NEURODEGENERATIVE DISEASE

ENHANCED MITOCHONDRIAL RESPONSE WITH THIOZOLIDINEDIONE, PIOGLITAZONE OR ROSIGLITAZONE

MONOCLONAL ANTIBODIES AGAINST PATHOLOGICAL TAU, AND METHODS USING SAME

METHOD OF USING HUMAN SPHEROIDS FOR DRUG DISCOVERY

METHODS FOR DETECTING A GENETIC VARIATION IN ATTRACTIN-LIKE 1 (ATRNL1) GENE IN SUBJECT WITH PARKINSON'S DISEASE

METHOD OF MICROGLIA DIFFERENTIATION CAPABLE OF SECURING LARGE QUANTITY OF MICROGLIA BY USING 3D ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS

Method and System for Imaging and Analysis of a Biological Specimen

RETINAL PIGMENTED EPITHELIUM AND PHOTORECEPTOR DUAL CELL AGGREGATES AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS OF PRO-ORGAN FORMATION ON PARTICLE SUBSTRATES AND USES THEREOF

SYSTEMS FOR DETECTION

SYSTEM AND METHOD FOR TESTING EFFECTS OF CHEMICAL COMPOUNDS ON COGNITIVE FUNCTION

METHODS FOR QUANTIFICATION OF COMPOUNDS IN CULTIVARS OF Cannabis sp.

SYSTEM AND METHOD FOR TRAINING IN VITRO NEURONS USING HYBRID OPTICAL/ELECTRICAL SYSTEM

Modulation of Microglia Activation

Engineered 3D-Printed Artificial Axons

THERAPIES FOR THE TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH ABNORMAL EXPRESSION OF A NEURAL-ASSOCIATED GENE

METHODS OF THERAPEUTIC PROGNOSTICATION

METHOD AND REAGENTS TO IMPROVE NONANIMAL OCULAR TOXICITY TESTS

Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis (ALS) by UPF2

DIFFERENTIATION METHOD FOR PROCURING LARGE AMOUNT OF CELLS BY CHOPPING 3D ORGANOIDS PREPARED FROM HUMAN PLURIPOTENT STEM CELLS

Methods of Modifying Neuronal Function by Changing Intracellular Magnesium Levels

CULTURE SYSTEM AND METHODS FOR IMPROVED MODELING OF NEUROLOGICAL CONDITIONS

BIOMIMETIC NERVE CHIP FOR EVALUATING EFFICACY AND TOXICITY ON NERVE, AND USE THEREOF

MITOTHERAPEUTICS FOR THE TREATMENT OF BRAIN DISORDERS

SYSTEMS FOR DETECTION

USE OF PAK4 AND CRTC1 FOR TREATMENT OR DIAGNOSIS OF BRAIN DEGENERATIVE DISEASE

METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs)

TARGETING THE NEUROLIGIN-3 BINDING PARTNER CSPG4 IN GLIOMA

METHODS AND COMPOSITIONS FOR TREATING ALZHEIMER'S DISEASE

Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species

SYSTEMS AND METHODS FOR IN-VITRO MODELING OF NEURODEGENERATIVE DISEASES

Cell-based Clostridal Neurotoxin Assays

DRUG FINGERPRINTING

BIOLOGICALLY RELEVANT IN VITRO SCREENING OF HUMAN NEURONS

FUNCTIONAL NEUROMODULATORY ASSEMBLOIDS

BRAIN-CHIP MODELING NEURODEGENERATION AND NEUROINFLAMMATION IN PARKINSON'S DISEASE

THREE DIMENSIONAL HETEROGENEOUSLY DIFFERENTIATED TISSUE CULTURE

PLURIPOTENT STEM CELL, NERVE CELL, AND APPLICATION THEREOF

METHOD FOR INDUCING HIBERNATION-LIKE STATE AND DEVICE SAME

NOVEL LIVE-CELL ASSAY FOR NEURONAL ACTIVITY

UNIVERSAL ODOR CODE SYSTEMS AND ODOR ENCODING DEVICES

A Method Of Promoting Survival And/Or Function Of A Motor Neuron And Related Agents, Uses And Methods

COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISEASES

CLSP DERIVATIVE INCAPABLE OF BEING AFFECTED BY CLSP INHIBITING SUBSTANCE, AND CLSP ACTIVITY ENHANCING/PROTECTING AGENT

BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS

BIO-INK FORMULATIONS, BIO-PRINTED CORNEAL LENTICULE, AND APPLICATIONS THEREOF

Treating myelin diseases with optimized cell preparations

APOLIPOPROTEIN E FRAGMENTS

Adeno-Associated Virus Virions with Variant Capsid and Methods of Use Thereof

REPRODUCIBLE BRAIN ORGANOIDS AND METHODS OF MAKING

Generation of norepinephrine neurons from human stem cells

METHOD OF NOCICEPTOR DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS AND USES THEREOF

Assembly of functionally integrated human forebrain spheroids and methods of use thereof

A MICRO PHYSIOLOGICAL MODEL FOR NEURONAL AND MUSCULAR DISEASES AND DISORDERS

CHANNELRHODOPSINS FOR OPTICAL CONTROL OF CELLS

Oligonucleotides for inducing paternal UBE3A expression

METHODS AND COMPOSITIONS FOR RESTORING STMN2 LEVELS

METHOD FOR PRODUCING ASTROCYTES

Production method for retinal tissue

Human Genomic Construct Reporter Cells and Mouse Models to Screen Therapeutics against Microglia-expressed Disease Associated Genes

IN VITRO HUMAN BLOOD BRAIN BARRIER

METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES USING FNDC5

SLEEP MODULATION AGENT

MANUFACTURE OF STRUCTURE CAPABLE OF FORMING THREE-DIMENSIONAL NEURONAL SPHEROID AND GENERATING NEURITE THROUGH VARIOUS SURFACE PROCESSES

DERIVATION OF HUMAN MICROGLIA FROM PLURIPOTENT STEM CELLS

Human Pluripotent Stem Cell-Based Models for Predictive Developmental Neural Toxicity

CELL-BASED METHOD FOR DETERMINING AN ACTIVITY OF BOTULINUM TOXIN

Formulations and methods related to eye irritation

SYSTEMS AND METHODS FOR IDENTIFYING AND TREATING NEURODEGENERATIVE DISEASE

Optical clearing and auto-fluorescence quenching solutions and method of use for enhanced microscopy imaging of biological tissues

MICROGLIA DERIVED FROM PLURIPOTENT STEM CELLS AND METHODS OF MAKING AND USING THE SAME

Methods of making hydraulic fracturing fluids and use thereof

NON-HUMAN ANIMAL EXHIBITING DIMINISHED UPPER AND LOWER MOTOR NEURON FUNCTION AND SENSORY PERCEPTION

Methods and systems for screening therapeutic compositions for treating age-related macular degeneration

METHODS AND COMPOSITIONS FOR CHARACTERIZATION OF GLIOBLASTOMA MULTIFORME TUMORS AND CANCER STEM CELLS

Neurodegenerative disorders

CO-CULTURING DEVICE, MOTOR NEURON CULTURING DEVICE, MULTI-WELL PLATE, FABRICATION METHOD OF IN VITRO EVALUATION MODEL OF NEUROMUSCULAR DISEASE, AND SCREENING METHOD OF THERAPEUTIC AGENT AGAINST NEUROMUSCULAR DISEASE

Lyophilized mesenchymal stem cell derived secretome and uses thereof

METHOD FOR OBTAINING ARTIFICIAL NEUROMUSCULAR JUNCTION FROM PLURIPOTENT STEM CELLS

SCREENING AGENTS CAPABLE OF INHIBITING PAIN AND/OR PRURITUS AND METHODS AND COMPOSITIONS FOR TREATING PAIN AND/OR PRURITUS USING SAID AGENTS

Method for measuring immunostimulatory response of immune cell, method for determining ability to form immune synapse in immune cell, and cell analyzer

COMBINATORIAL USE OF MARKERS TO ISOLATE SYNAPTIC GLIA TO GENERATE SYNAPSES IN A DISH FOR HIGH-THROUGHPUT AND HIGH-CONTENT DRUG DISCOVERY AND TESTING

DEVICE AND SYSTEMS COMPRISING ELECTRODE ARRAYS FOR ELECTROCONDUCTIVE CELLS

Systems for detection

Compositions and methods for modulating neuronal excitability and motor behavior

STEM CELL-DERIVED CELL CULTURES, STEM CELL-DERIVED THREE DIMENSIONAL TISSUE PRODUCTS, AND METHODS OF MAKING AND USING THE SAME

Methods and Compositions for Retinal Neuron Generation in Carrier-Free 3D Sphere Suspension Culture

CHEMICAL COCKTAIL FOR INDUCING SENESCENCE IN HUMAN NEURONS TO PROMOTE DISEASE MODELING AND DRUG DISCOVERY

KIT, METHOD FOR SCREENING AN ACTIVE COMPOUND IN VITRO AND USES OF A KIT

Antibody binding to chondroitin sulfate proteoglycan 5

MEASUREMENT METHOD

SYSTEMS FOR DETECTION

METHOD FOR DETERMINING DECREASE IN FUNCTIONS OF HIPPOCAMPUS BY USING CORRELATION BETWEEN MICRO RNA AND NMDA RECEPTOR, METHOD FOR INHIBITING DECREASE IN FUNCTIONS, AND METHOD FOR SCREENING FOR INHIBITORS OF DECREASE IN FUNCTIONS

Method for measuring intracellular potential with a capacitance type potential measurement device

METHODS FOR PRODUCING RETINAL TISSUE AND RETINA-RELATED CELL

STEM CELL-DERIVED HUMAN MICROGLIAL CELLS, METHODS OF MAKING AND METHODS OF USE

METHOD FOR INDUCING DIFFERENTIATION INTO PLURIPOTENT STEM CELL-DERIVED CONJUNCTIVAL CELLS

MICROELECTRODE ARRAY AND USES THEREOF

Human induced pluripotent stem cell lines for modeling Alzheimer's disease and usage thereof

INDUCTION OF MYELINATING OLIGODENDROCYTES IN HUMAN CORTICAL SPHEROIDS

SEPTAPEPTIDES ASSOCIATED WITH NEURODEGENERACY

BLOOD BRAIN BARRIER MODELS AND METHODS TO GENERATE AND USE THE SAME

TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM

Human pluripotent stem cell derived neurodegenerative disease models on a microfluidic chip

METHOD AND COMPOSITION FOR GENERATING BASAL FOREBRAIN CHOLINERGIC NEURONS (BFCNs)

Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain

METHODS AND COMPOSITION FOR MODULATING IMMUNE RESPONSE AND IMMUNE HOMEOSTASIS

Neurodegenerative target discovery platform

Methods for diagnosing and treating Alzheimer's disease

Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide

Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide

Cell-based method for determining an activity of botulinum toxin

Control and Characterization of Psychotic States

DIRECTED DIFFERENTIATION OF ASTROCYTES FROM HUMAN PLURIPOTENT STEM CELLS FOR USE IN DRUG SCREENING AND THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Involuntary response stimulator and therapy

Fluorogenic pH sensitive dyes and their method of use

METHOD FOR PRODUCING TAU-RELATED DISEASE MODEL

Compositions comprising cyclic peptides derived from an A-beta peptide

METHOD FOR IDENTIFYING EFFECTIVE TREATMENTS AGAINST NEURODEGENERATIVE DISORDERS

Nerve cell device and method for evaluating neural activity

Non-invasive, in vitro functional tissue assay systems

METHODS AND DEVICES FOR LIVE CELL IMAGING ANALYSIS

DRUG EVALUATION METHOD

METHOD OF USING HUMAN SPHEROIDS FOR DRUG DISCOVERY

Differentiation of pluripotent cells into microglial cells expressing IBA-1

Nervous system-specific transmembrane proteasome complex that modulates neuronal signaling through extracellular signaling via brain activity peptides

CELL SYSTEMS USING SPHEROIDS AND METHODS OF MAKING AND USING THE SAME

COMPOSITIONS AND METHODS FOR THE GENERATION OF NEURONS AND USES THEREOF

EFFICIENT, SCALABLE PRODUCTION OF HUMAN RETINAL PROGENITORS IN VITRO

Functional cortical organoids, methods of making, and uses thereof

Oligonucleotides for inducing paternal UBE3A expression

3D CELL CULTURE

Cell-based method for determining an activity of botulinum toxin

Cell-based method for determining an activity of botulinum toxin

BLOOD BRAIN BARRIER MODEL

Cell-based method for determining an activity of botulinum toxin

Drug for retinal degenerative disease associated with photoreceptor degeneration

Method for determining decrease in functions of hippocampus by using correlation between micro RNA and NMDA receptor, method for inhibiting decrease in functions, and method for screening for inhibitors of decrease in functions

Agent for accelerating maturation or aging of cells

TUMOR ORGANOID MODEL

Anti-FAM19A5 antibodies and uses thereof

Methods of modifying neuronal function by changing intracellular magnesium levels

Cell-based assay using electrophysiological activity measured with microelectrode arrays

Assembly of functionally integrated human forebrain spheroids and methods of use thereof

Channelrhodopsins for optical control of cells

Benzimidazole-carboxamide compounds as 5-HTreceptor agonists

Methods for obtaining pluripotent adult olfactory stem cells from an olfactory mucosa tissue

Method for preparation of retinal ganglion cells

Methods for building genomic networks and uses thereof

TENEURIN C-TERMINAL ASSOCIATED PEPTIDES (TCAP) AND METHODS AND USES THEREOF

In vitro model for neuronal death

Methods of producing bioengineered neuronal organoids (BENOs) and uses thereof

Multiwell cell culture system having rotating shafts for mixing culture media and method of use thereof

Brain derived PPARα ligands

DIAGNOSTIC METHODS FOR NEURAL DISORDERS

TEMOZOLOMIDE RESISTANT CELLS AND AN INTEGRATED METHOD FOR CHARACTERIZING THE SAME

Screening method for pain suppressor and pharmaceutical composition for prevention or treatment of pain

USE OF P97 AS AN ENZYME DELIVERY SYSTEM FOR THE DELIVERY OF THERAPEUTIC LYSOSOMAL ENZYMES

Cell-based method for determining an activity of botulinum toxin

Method for differentiation into retinal ganglion cells from stem cells

COMPOUNDS FOR TREATMENT OF DISEASES AND METHODS OF SCREENING THEREFOR

Layerless bioprinting via dynamic optical projection and uses thereof

Detection and treatment of neurological diseases

Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain

Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity by UPF1

Compositions and methods for in vitro assays of fibrin activity

METHODS AND SYSTEMS FOR DETERMINING SYNAPSE FORMATION

Methods for the treatment of neurological disorders and diseases using FNDC5

Method and system for imaging and analysis of a biological specimen

Method for generating retinal pigment epithelium (RPE) cells from induced pluripotent stem cells (IPSCs)

STEM CELL MODEL OF APOE GENOTYPE AND Abeta42-DEPENDENT NEURODEGENERATION AND METHODS OF USING THE SAME

COMPOUNDS FOR TREATMENT OF INTRACTABLE EPILEPSY AND DOORS SYNDROME

SYSTEMS

IN VITRO MODEL FOR NEURONAL DEATH

OPTOGENETIC THERAPEUTIC AND METHOD OF TREATING RETINAL DEGENERATIVE AND NEURODEGENERATIVE DISEASES

Neuronal survival and axonal regeneration through increasing mitochondrial motility

Oligonucleotides for inducing paternal UBE3A expression

Channelrhodopsins for optical control of cells

Three-Dimensional Human Neural Tissues for CRISPR-Mediated Perturbation of Disease Genes

METHOD OF IDENTIFYING AGENTS THAT AFFECT MATURATION, SURVIVAL AND MYELINATION

Biomaterials for neuronal implants and use of said biomaterials in the diagnosis and therapy of neuronal diseases

Methods of selecting therapeutic molecules

Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species

Marker for Neural Stem Cells

Basal ganglia-on-chip for screening therapeutic agents for brain and nervous system diseases

IMMORTALIZATION OF CELLS INCLUDING NEURONAL CELLS

Channelrhodopsins for optical control of cells